HYALURONIC ACID INJECTION
Monovisc
HYALURONIC ACID INJECTION
Monovisc
Monovisc® is a single injection viscosupplement utilized to treat knee joint pain caused by osteoarthritis (OA). It is the only non-animal sourced hyaluronic acid (HA) single-injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.
MONOVISC® is comprised of highly purified, cross-linked sodium hyaluronate in a phospate buffered saline solution and it is both biocompatible and resorbable. It restores the molecular weight, elasticity and viscosity of the osteoarthritic knee to more closely resemble the synovial fluid of a healthy knee. The single injection regimen provides many advantages with decreased visits to the doctor and reduced risk or discomfort associated with multiple injections.
With just one injection, this FDA-approved viscosupplement may provide pain relief that lasts for up to 6 months.
Monovisc: A High Molecular Weight Hyaluronic Acid Single Injection OA Treatment
Monovisc® is a single injection viscosupplement utilized to treat knee joint pain caused by osteoarthritis (OA). It is comprised of highly purified, partially cross-linked sodium hyaluronate (NaHA) in a phosphate buffered saline solution, and it is both biocompatible and resorbable.
With just one injection, Monovisc may provide pain relief that lasts for up to 6 months.1 It is the only non-animal sourced hyaluronic acid (HA) single-injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.
Key Features & Benefits
Convenient single injection treatment Highly concentrated, non-animal sourced HA Long lasting relief through 26 weeks Convenience of a single injection as opposed to multiple visits to the physician No confirmed pseudoseptic reactions reported 
Related Brands
